Trade Secrets

Pfizer acts quickly to tackle alleged covid-19 vaccine trade secrets misappropriation

With strong policies in place to protect confidential information, the company was able to take swift action against an employee after becoming aware of suspicious activity

Pfizer acts quickly to tackle alleged covid-19 vaccine trade secrets misappropriation
Talks over covid vaccine IP waiver appear increasingly futile
23 Oct 2021

Talks over covid vaccine IP waiver appear increasingly futile

Saturday Opinion: The prospect of an international agreement on the proposed suspension of TRIPS now appears vanishingly small

Hub and spoke IP strategies are generating billions of dollars in biopharma
22 Oct 2021

Hub and spoke IP strategies are generating billions of dollars in biopharma

New Crinetics spin-off is more evidence of the growing influence of models designed to monetise non-core life sciences assets

Latest

View all
22 Oct 2021

What to know about Baosteel: the Chinese giant behind Japan’s biggest patent dispute

The state-owned firm has moved up the value chain despite its limited overseas patent holdings, but it is no stranger to high-stakes IP legal fights abroad Read more

15 Oct 2021

Moderna’s covid-19 patent pledge may be backfiring

Though a short-term PR success, the company’s commitment risks looking hollow after its decision not to license know-how to new WHO Africa tech-transfer hub Read more

15 Oct 2021

AbbVie suffers knock-back in Humira trade secrets dispute

Illinois district court dismisses case relating to alleged misappropriation outside the US Read more

1 Oct 2021

Biopharma IP licensors are getting more money - and earlier - for their innovations

M&A may be stagnant, but innovators are receiving larger upfront payments for partnership agreements Read more

News

View all
25 Aug 2021

IAM parent company acquires market-leading US patent litigation data and analytics firm

Austin-based Docket Navigator - which also covers trademarks, antitrust and other practice areas - becomes a Law Business Research company Read more

26 Jun 2021

For India and other countries, an IP waiver is a distraction not a solution to the covid-19 vaccine crisis

A TRIPs suspension will not provide the shot in the arm that millions of Indians need, but the country does have a major role to play in supplying vaccines to the world Read more

8 May 2021

Biden’s backing for the covid vaccine IP waiver should concern all rights owners

This week’s unprecedented move raises a series of worrying questions and puts in doubt the administration’s commitment to fostering innovative activity Read more

19 Nov 2020

Your guide to covid-19 vaccine stakeholders’ IP strategies

IAM examines the approaches taken by – and the issues facing – the leading companies in the race to find effective coronavirus inoculations Read more

Analysis

View all
1 Oct 2021

TSMC has catalogued more than 140,000 trade secrets since 2013, company says

Chipmaker has operated a trade secret registration system for eight years, and is now looking to shore up management practices among its suppliers Read more

24 Sep 2021

Moderna’s covid-19 IP pledge is about to be put to the test

The WHO’s African vaccine hub is seeking to imitate the company’s jab, but an agreement has yet to be reached Read more

3 Sep 2021

Why the delay in picking a new USPTO director really matters

Acting head Drew Hirshfeld says he’s focused on doing the best job possible, but some fear that without a permanent political appointee the agency could be hamstrung Read more

3 Sep 2021

Bolsonaro vetoes Brazil’s first-of-a-kind compulsory tech transfer law

The president’s rejection of forced know-how licensing will now be reviewed by the country’s Congress, but a new patent suspension regime is set to come into force Read more

Insights

View all
8 Jun 2020

From French fancy to global community – celebrating 100 issues of IAM 

Founder and editor in chief Joff Wild looks back on 17 years of IAM Read more